Search results

Page results

• FACETS: A Fatigue Management Group

  This page explains what FACETS is and how it can help you.

• UCLH top in England in CQC inpatient survey for the second year running

  UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.

• First patient takes part in new Phase 1 clinical trial for patients with recurrent glioblastoma

  To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer. 

• Induction of labour when your baby is overdue or ‘post-dates’

  This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.

• Doctors urged to treat patients with sudden hearing loss within seven days

  A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.

• Integrated General Medicine Service

  Information about the Integrated General Medicine Service at the RLHIM patient information leaflet.

• Extreme lateral lumbar fusion (XLIF)

  This page provides general information about extreme lateral lumbar fusion and decompression (XLIF®).

• Fibreoptic Endoscopic Evaluation of Swallow (FEES)

  Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet

• Post procedural care diagnostic angiogram and endovascular treatment

  This page provides information about post procedural care following a diagnostic angiogram or endovascular treatment and possible complications that may occur.

• The Female Genital Cutting / Mutilation (FGC/M) Children and Young People’s Clinic

  The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.